Načítá se...
Drug-induced reduction in estimated glomerular filtration rate in patients with ALK-positive non-small cell lung cancer treated with the ALK-inhibitor crizotinib
BACKGROUND: Renal side effects of crizotinib have not been investigated previously. METHODS: Estimated Glomerular Filtration Rate (eGFR) was calculated using the CKD-EPI creatinine-based prediction equation during the first 12 weeks of crizotinib and post-crizotinib prior to the introduction of any...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3949169/ https://ncbi.nlm.nih.gov/pubmed/24258622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28478 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|